Cargando…
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
BACKGROUND: High oxidative stress and chronic inflammation can contribute to the pathogenesis of coronary artery disease (CAD). Coenzyme Q10 is an endogenous lipid-soluble antioxidant. Statins therapy can reduce the biosynthesis of coenzyme Q10. The purpose of this study was to investigate the effec...
Autores principales: | Lee, Bor-Jen, Tseng, Yu-Fen, Yen, Chi-Hua, Lin, Ping-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176102/ https://www.ncbi.nlm.nih.gov/pubmed/24192015 http://dx.doi.org/10.1186/1475-2891-12-142 |
Ejemplares similares
-
Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
por: Dohlmann, Tine L., et al.
Publicado: (2022) -
Effect of Coenzyme Q(10) Supplementation in Statin-Treated Obese Rats
por: Choi, Hye-Kyung, et al.
Publicado: (2016) -
The Antioxidant Status and Concentrations of Coenzyme Q10 and Vitamin E in Metabolic Syndrome
por: Yen, Chi-Hua, et al.
Publicado: (2013) -
The Relationship between Coenzyme Q10, Oxidative Stress, and Antioxidant Enzymes Activities and Coronary Artery Disease
por: Lee, Bor-Jen, et al.
Publicado: (2012) -
Ubiquinone Supplementation with 300 mg on Glycemic Control and Antioxidant Status in Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Ho, Chien-Chang, et al.
Publicado: (2020)